Stanford's licensing and equity practices with biotechnology companies

Journal of Commercial Biotechnology

Volumn 11, Issue 4, 2005, Pages 318-324

  Leute, Kirsten ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Biotechnology; Equity; Start up; Technology transfer

Indexed keywords

FINANCE; INDUSTRY; INTELLECTUAL PROPERTY; TECHNOLOGY TRANSFER;

BIOTECHNOLOGY COMPANIES; LICENCE AGGREEMENT;

BIOTECHNOLOGY;

ARTICLE; BIOTECHNOLOGY; CONFLICT; ECONOMICS; FINANCIAL MANAGEMENT; INDUSTRY; INFORMATION PROCESSING; INTERPERSONAL COMMUNICATION; LICENSING; PATENT; PROFESSIONAL PRACTICE; TECHNOLOGY; UNIVERSITY;

EID: 24944589253     PISSN: 14628732     EISSN: None     Source Type: Journal    
DOI: 10.1057/palgrave.jcb.3040132     Document Type: Article

References (5)

1. Stanford University Research Policy Handbook, Document 4.6, Equity Acquisition in Technology Licensing and Distance Learning Agreements, last updated 1st May, 2001 (URL: http://www.stanford.edu/dept/DoR/rph/ 4-6.html).
2. Edwards, M. G., Murray, F. and Yu, R. (2003), 'Value creation and sharing among universities, biotechnology and pharma', Nature Biotechnol., Vol.21(6), pp. 618-624.
3. Stanford University Research Policy Handbook, Document 4.3, Outside Consulting Activities by Members of the Academic Council, last updated 10th May, 2003 (URL: http://www.stanford.edu/dept/DoR/rph/4-3.html).
4. Bouchie, A. (2005), 'Survey reveals university licensing up, startup formation down', Nature Biotechnol., Vol.23(2), pp. 261-262.
5. URL: http://otl.stanford.edu/about/resources/equity.html